Lycia Therapeutics (LYCA) stock

Degrade disease proteins , market cap $1.6B

Novel therapeutics to degrade proteins

Market cap $1.6B

$28.85

-3.83%

As of 7:29 PM ET after-hours, delayed 15+ min · Live for Pro members

Quality Score

New listing

Checks firing

1of 14

Transition

From its high

-20.9%

No 200-day yet

Trading since Oct 23, 2026. 2 trading days so far, so 12 of the 14 chart checks wait for more history.

Follow LYCA's trial news. Pro members can get an alert when Lycia Therapeutics files news, and see its trials, share raises, and its CEO's filings.

Get an alert when LYCA files news on its trialSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

We do the work for you. Every stock is scored and ranked, every 15 seconds while the market is open. Here it's 15 minutes behind. Pro members see it live.

Key facts on LYCA

Key facts on LYCA
Latest filing	8-K, Oct 26 Changed its bylaws or fiscal year

LYCA in the news

TodayNo story names it yet.

LYCA catalysts

1 past catalyst since 2026, with sizes and sources, for Pro members.Get in free →

What's next for LYCA

Its trials

A trial underway: Single Ascending and Multiple Ascending Dose Study of LCA-0061Phase 1 · Recruiting · 72 people · main data estimated Apr 2028 · NCT07701954

For Pro members: 1 filing.

Dilution on the horizon

No shelf registration or at-the-market program on file in the last three years.

For Pro members: 1 raise and its amount, and the share count against a year ago.

Insiders

No open-market buys or sales by its officers or directors in their filings of the last year.

From Form 4: open-market buys and sales only.

Get an alert when Aetna Trombley buys or sells

For Pro members: every trade, and Aetna Trombley’s 1 filing and quote.

Get an alert when LYCA files news on its trialSee it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

See every upcoming FDA date →

FDA dates in the next 60 days

Decision dates and advisory committee meetings the companies have announced in their filings, soonest first and small companies first.

DateStockDrug

In 15 daysANDA decisionIn 15 days · ANDA decisionNRXPNRX PharmaceuticalsPreservative-free ketamineNRXPNRX Pharmaceuticals · $104MPreservative-free ketamineA generic, under FDA review (GDUFA)
In 27 daysFDA decisionIn 27 days · FDA decisionCAPRCapricor TherapeuticsDeramiocelCAPRCapricor Therapeutics · $356MDeramiocelFDA decision due (PDUFA)
In 27 daysFDA decisionIn 27 days · FDA decisionSVRASavaraMolgramostimSVRASavara · $933MMolgramostimFDA decision due (PDUFA)

10 more FDA dates and 103 trial data dates in the next 60 days, each on the FDA calendar. Pro members see whether each company's cash lasts past its date, with an optional alert before it. See all 168 dates, ranked →

Why LYCA scores 1

New listingTransition, 1 of 14 chart checks firingWhat the Quality Score means

+1Chart checks 1 of 14 firing right now, one point each
0Long-term trend 2 sessions listed, no 200-⁠day average yet

No effect today: Run-up, Size, Profit, Growth, Dilution, Cash flow, Persistence, and News.

What every line is worth, and the reason behind it, on LYCA and every other stock.Get in free →

Price, score, chart checks, and the industry rank are from a snapshot taken at 7:29 PM ET, at least 15 minutes behind. How we rank stocks.

Tested. Our top-⁠scored stocks returned 2.2x the average stock over the next month. How we tested it

Alert me when LYCA's Quality Score turns up

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Here is what Pro members see.

The same page for Pro members, on AMD
Its Quality Score and rank, the line that drives it, and the live price.
The full chart
A year of candles to start, out to the whole history, with insider trades marked and the Quality Score under the price.
Every line of the score
Price action, the company, and signals, each with its points, on LYCA and every other stock.
FDA dates, counted down
Each date in the company's words, its cash against the date, and an optional alert before it.
CEOs buying their own stock
Every CEO buy, biggest names first. Sort, filter, save the list, and set optional alerts.
Congress trades
A member's trades, newest first, each with its amount. Sort and filter the whole list.
14 chart checks, read for you
The ones firing on the stock, each in plain words, its rule a tap away.
Earnings, week by week
Who reports each day, and how each stock took its last four reports.
The market map
Every stock a box, colored by its Quality Score.
Themes, ranked live
Each theme's stocks ranked by Quality Score, live. Here, AI chips.
The top 10, every day
The ten highest Quality Scores at each close, kept day by day, week by week.
Optional alerts, your way
Pick a stock, a score, a price, a filing, or a whole scan. It tells you by push or email.
Your watchlist, scored
Your stocks by Quality Score, today's move, or name.
On your phone and your laptop
The same account and watchlist on both, each laid out for its screen.

Prices refresh every 2.5 seconds during market hours.
Optional alerts by push, email, or the bell.
Add it to your Home Screen and it opens like an app.

LYCA has 1 of 14 chart checks firing

Trend1 of 5 shown

MA FAN 21 EMA W.EMA HH/HL 52W HI

Volume1 of 3 shown

VOL VDU U/D VOL

Tight range1 of 3 shown

ATR SQZ SQUEEZE NR7

Buying1 of 3 shown

OBV+CLOSE HI SPRING

The other 10 checks on LYCA, and all 14 on every stock.Get in free →

The deep dive on LYCA

What it does and how it makes money1 findingFor Pro members1 finding on what LYCA does and how it makes money, for Pro members

1 more finding on LYCA, each with its source, for Pro membersGet in free →

How LYCA ranks in Biotech

LYCA is a new listing, ranked from its 22nd trading day.

How LYCA ranks in Biotech
1	HALOHalozyme Therapeutics	9/14	21
2	RIGLRigel Pharmaceuticals	9/14	19
3	MEDPMedpace	7/14	19
	LXEOLexeo Therapeutics		Open for its score
	LXRXLexicon Pharmaceuticals		Open for its score
	MAIAMAIA Biotechnology		Open for its score
	MAZEMaze Therapeutics		Open for its score
New	LYCALycia Therapeutics	1/14	1

LYCA share count over time

Offerings, shelves, and splits of LYCA, from its filings
From its filings	Filed
Raised $317.5M in a sale of shares, about 20% of its market value	Oct 23, 2026
Registered shares for sale (S-1)	Oct 5, 2026

About Lycia Therapeutics

Lycia Therapeutics Inc is a clinical-stage biotechnology company focused on the discovery and development of novel therapeutics designed to degrade disease-causing extracellular proteins, with an initial focus on addressing autoimmune, inflammatory and allergic diseases.

lyciatx.com

Listed on Nasdaq on Oct 23, 2026, and is 60% above its $18 offer price now. Its IPO filing and first days

LYCA's score card

Lycia Therapeutics (LYCA): Quality Score 1, New listing, with its price, on Breakaway — The picture a link to this page shows when it is shared.

Pro members see every line of every stock's score.

What would turn LYCA's score around: 1 thing
2 more filings explained, a plain line each
Real-⁠time prices, no delay

See LYCA's 14 chart checks

See it live, free until Wednesday morning. No account. No card. Then keep going with a free account.

Straight Answers

As of Oct 26, 2026: LYCA's Quality Score is 1 (New listing).

Is LYCA a good stock to buy? What its Quality Score says

LYCA scores 1 today, which Breakaway calls Below Average. It has 1 of 14 chart checks firing. Breakaway does not say whether to buy any stock: the score does not know your situation, and it is not a recommendation to buy or sell anything. Please do your own research.

What is LYCA's Quality Score?

LYCA scores 1 today, which Breakaway calls Below Average (0 to 5). The score adds up the chart checks, the trend, the company's filed sales, its profits, the news, insider trades, and Congress trades. The section above lists the lines behind LYCA's 1.

Are the prices delayed?

Only on the public pages, which run at least 15 minutes behind. Pro members, and anyone on a guest pass, see real-time prices: the scanner refreshes every 15 seconds, and your watchlist every few seconds, pre-market and after hours included.